|
1
|
Heeg B, Van Agthoven M, van Beurden-Tan C, Liwing J, Mellqvist UH, Plesner T, Logman F, Aschan J, Einsele H, Treur M, Barendse M, Richardson PG, Palumbo A, Nahi H, Sonneveld P. Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT). Value Health 2014; 17:A617-A618. [PMID: 27202167 DOI: 10.1016/j.jval.2014.08.2182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- B Heeg
- Pharmerit International, Rotterdam, The Netherlands
| | | | | | - J Liwing
- Janssen-Cilag AB, Sollentuna, Sweden
| | | | | | - F Logman
- Eastbridge Pharma BV, Utrecht, The Netherlands
| | - J Aschan
- Janssen-Cilag AB, Sollentuna, Sweden
| | - H Einsele
- Medizinische Klinik II, Würzburg, Germany
| | - M Treur
- Pharmerit International, Rotterdam, The Netherlands
| | | | | | | | - H Nahi
- Karolinska University Hospital, Solna, Sweden
| | - P Sonneveld
- Erasmus University Medical Center, Rotterdam, The Netherlands
| |
Collapse
|
|
2
|
Thilakarathne P, Diels J, van Sanden S, Liwing J, Chirita O, Van Agthoven M, Nahi H. Bortezomib Re-treatment in Patients with Multiple Myeloma (MM). A Real World Medical Practice Experience from a Swedish National Registry. Value Health 2014; 17:A617. [PMID: 27202162 DOI: 10.1016/j.jval.2014.08.2181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
| | - J Diels
- Janssen Research & Development, Beerse, Belgium
| | - S van Sanden
- EMEA HEMAR Analytics, Janssen EMEA, Beerse, Belgium
| | - J Liwing
- Janssen-Cilag AB, Sollentuna, Sweden
| | | | | | - H Nahi
- Karolinska University Hospital, Solna, Sweden
| |
Collapse
|
|
3
|
Thilakarathne P, Diels J, van Sanden S, Liwing J, Van Agthoven M, Chirita O, Nahi H. Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden. Value Health 2014; 17:A545-A546. [PMID: 27201764 DOI: 10.1016/j.jval.2014.08.1767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
| | - J Diels
- Janssen Research & Development, Beerse, Belgium
| | - S van Sanden
- EMEA HEMAR Analytics, Janssen EMEA, Beerse, Belgium
| | - J Liwing
- Janssen-Cilag AB, Sollentuna, Sweden
| | | | | | - H Nahi
- Karolinska University Hospital, Solna, Sweden
| |
Collapse
|